Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study

BACKGROUND: The DYNAGITO study was a Phase IIIb, randomized, double-blind, multicenter, active-controlled, parallel-group, 52-week study designed to determine the efficacy and safety of tiotropium and olodaterol combination therapy (TIO+OLO 5/5 μg) versus tiotropium monotherapy (TIO 5 μg) for reduci...

Descripción completa

Detalles Bibliográficos
Autores principales: Ichinose, Masakazu, Nishimura, Masaharu, Akimoto, Manabu, Kurotori, Yasuhiro, Zhao, Yihua, de la Hoz, Alberto, Mishima, Michiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6049061/
https://www.ncbi.nlm.nih.gov/pubmed/30034230
http://dx.doi.org/10.2147/COPD.S169941

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6049061/
https://www.ncbi.nlm.nih.gov/pubmed/30034230
http://dx.doi.org/10.2147/COPD.S169941

Ejemplares similares